Biotech · Private company
Novatek Pharmaceuticals
Track this companyFree. Adds Novatek Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NP-101Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- TQ Formula/TabPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.PHASE2 · TERMINATED · started Feb 22, 2023ClinicalTrials.gov NCT05785390 · fetched Nov 12, 2026
- NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasPHASE1 · COMPLETED · started Dec 15, 2022ClinicalTrials.gov NCT05262556 · fetched Nov 12, 2026
- To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 ParticipantsPHASE2 · COMPLETED · started Jun 8, 2021ClinicalTrials.gov NCT04914377 · fetched Nov 12, 2026